Bio Cina Awarded Grant to Advance RNA Vaccines and Therapeutics
Details : The project, commencing in March will help BioCina address the post-pandemic mRNA demand for specific and essential attributes of new RNA products. It's anticipated the market will prioritize sophisticated LNP (lipid nanoparticle) formulations.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 04, 2022
Microba Accelerates Cancer Program With New Leads
Details : Microba’s Cancer Immuno-Oncology Neoadjuvant Therapy is targeting discovery and development of a microbiome therapy to improve response rates in cancer patients receiving immune checkpoint inhibitor (ICI) therapy, with a specific focus on Melanoma and ...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 05, 2022
Details : Collaboration will leverage Onko-Innate’s deep expertise in NK Cell Tumor Biology to discover novel therapies in immuno-oncology and cell therapy.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 21, 2020